Business Description
Bachem Holding AG
ISIN : CH1176493729
Compare
Compare
Traded in other countries / regions
BANB.Switzerland0QND.UKBCHMY.USABHM.GermanyBANB.Mexico IPO Date
2022-02-08Description
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 794.67 | |||||
| Equity-to-Asset | 0.76 | |||||
| Interest Coverage | 4813.11 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 10.26 | |||||
| Beneish M-Score | -2.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year EBITDA Growth Rate | 10.6 | |||||
| 3-Year EPS without NRI Growth Rate | 10.3 | |||||
| 3-Year Book Growth Rate | 37.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 18.39 | |||||
| Future 3-5Y Total Revenue Growth Rate | 19.84 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.41 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 0.79 | |||||
| Days Inventory | 332.96 | |||||
| Days Sales Outstanding | 93.3 | |||||
| Days Payable | 30.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 7.7 | |||||
| 3-Year Average Share Buyback Ratio | -2.3 | |||||
| Shareholder Yield % | 1.16 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.04 | |||||
| Operating Margin % | 22.49 | |||||
| Net Margin % | 19.66 | |||||
| FCF Margin % | -9.38 | |||||
| ROE % | 8.79 | |||||
| ROA % | 6.94 | |||||
| ROIC % | 8.63 | |||||
| ROC (Joel Greenblatt) % | 11.23 | |||||
| ROCE % | 8.88 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.8 | |||||
| Forward PE Ratio | 39.23 | |||||
| PE Ratio without NRI | 44.85 | |||||
| Shiller PE Ratio | 72.3 | |||||
| Price-to-Owner-Earnings | 216.56 | |||||
| PEG Ratio | 2.86 | |||||
| PS Ratio | 9.01 | |||||
| PB Ratio | 3.98 | |||||
| Price-to-Tangible-Book | 4.02 | |||||
| Price-to-Operating-Cash-Flow | 21.38 | |||||
| EV-to-EBIT | 38.3 | |||||
| EV-to-Forward-EBIT | 52.02 | |||||
| EV-to-EBITDA | 27.91 | |||||
| EV-to-Forward-EBITDA | 40.08 | |||||
| EV-to-Revenue | 8.48 | |||||
| EV-to-Forward-Revenue | 11.63 | |||||
| EV-to-FCF | -92.14 | |||||
| Price-to-Projected-FCF | 5.27 | |||||
| Price-to-DCF (Earnings Based) | 1.42 | |||||
| Price-to-Median-PS-Value | 1.3 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.95 | |||||
| Price-to-Graham-Number | 2.83 | |||||
| Price-to-Net-Current-Asset-Value | 15.61 | |||||
| Earnings Yield (Greenblatt) % | 2.61 | |||||
| FCF Yield % | -1.02 | |||||
| Forward Rate of Return (Yacktman) % | 15.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bachem Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 11,600.732 | ||
| EPS (TTM) (MXN) | 30.298 | ||
| Beta | 0 | ||
| Volatility % | 0.87 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 1741.42 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 1741.42 - 1741.42 | ||
| Shares Outstanding (Mil) | 74.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bachem Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bachem Holding AG Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bachem Holding AG Frequently Asked Questions
What is Bachem Holding AG(MEX:BANB)'s stock price today?
The current price of MEX:BANB is MXN1741.42. The 52 week high of MEX:BANB is MXN1741.42 and 52 week low is MXN1741.42.
When is next earnings date of Bachem Holding AG(MEX:BANB)?
The next earnings date of Bachem Holding AG(MEX:BANB) is .
Does Bachem Holding AG(MEX:BANB) pay dividends? If so, how much?
Bachem Holding AG(MEX:BANB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers